Walgreen Co. announced a 20 percent profit for its fiscal first-quarter, attributing the boost to increased prescription drug sales and flue shots.
The company earned $489 million, or 49 cents per share, up from $408 million, or 41 cents per share, a year prior. Excluding 3 cents per share in restructuring costs, the company said it earned 52 cents per share. Wall Street forecasts called for 48 cents per share in profit on just under $16.3 billion in revenue.
In morning trading, Walgreen shares fell 47 cents to $36.17
About EQUITIES:
Since 1951, EQUITIES Magazine has been a leading media company providing business editorial content designed to serve the needs of business leaders, professionals, institutional investors and retail investors. We are focused on business and the business of making money, not on lifestyle subjects. We publish original reporting in print and on our website, as well as select content at www.nasdaq.com. For 28 years we have hosted our own branded investor conferences that connect public company CEO’s with our loyal readers in the investment community.
Sign up for a free one-year subscription to EQUITIES Magazine
